Data on embryonic lethality is used by regulatory bodies to guide the development of safety standards and regulations. It informs the risk assessment process, helping to determine safe exposure limits for humans, particularly for vulnerable populations such as pregnant women. This information is also crucial for the pharmaceutical industry, as it informs drug development and helps in the identification of potential adverse effects during clinical trials.
